Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.448
+0.014 (3.13%)
At close: Jun 26, 2026, 4:00 PM EDT
0.456
+0.008 (1.85%)
After-hours: Jun 26, 2026, 7:26 PM EDT
Vivos Therapeutics Employees
Vivos Therapeutics had 270 employees as of March 31, 2026. The number of employees increased by 2 or 0.75% since the number was last reported on December 31, 2025.
Employees
270
Change
2
Growth
0.75%
Revenue / Employee
$72,474
Profits / Employee
-$92,548
Market Cap
6.22M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Trinity Biotech | 287 |
| VolitionRx | 67 |
| Beyond Air | 61 |
| Intelligent Bio Solutions | 55 |
| Biomerica | 54 |
| enVVeno Medical | 33 |
| Sintx Technologies | 32 |
| Tenon Medical | 26 |
VVOS News
- 4 days ago - Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity - GlobeNewsWire
- 15 days ago - Vivos Therapeutics intends to file registration statement for rights offering - TheFly
- 15 days ago - Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering - GlobeNewsWire
- 16 days ago - Vivos Therapeutics enters pact with South Palm Cardiovascular Associates - TheFly
- 16 days ago - Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients - GlobeNewsWire
- 17 days ago - Vivos Therapeutics Transcript: WTR Insights Conference: Powered by The Small Cap Showcase - Transcripts
- 18 days ago - Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026 - GlobeNewsWire
- 21 days ago - Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing - GlobeNewsWire